References
- Charman S, Charman W. (2003). Oral modified-release delivery systems. In: Rathbone M, Hadgraft J, Roberts M, eds. Modified-release drug delivery technology. New York: Marcel Dekker, Inc.
- Seager H. (1985). Soft gelatin capsules: A solution to many tableting problems. Pharm Technol, 9:84–104.
- Wong P, Dong L, Wan J. (2002). Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings. US Patent No. 6,419,952.
- Chung M, Reitberg D, Gaffney M, Singleton W. (1987). Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled release formulation of nifedipine. Am J Med, 83:10–4.
- Foster T, Hamann S, Richards V, Bryant P, Graves D, McAllister R. (1983). Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol, 23(4):161–70.
- Mcevoy G. (2000). AHFS drug information. Bethesda, MD: The American Society of Health system Pharmacists, Inc.
- Swanson D, Barclay B, Wong P, Theeuwes F. (1987). Nifedipine gastrointestinal therapeutic system. Am J Med, 83(Suppl. 6B):3–9.
- Bayer Corporation Pharmaceutical Division. (2000). Adalat CC® (nifedipine) tablet package insert. West Haven, CT.
- Pfizer Labs. (1997). Procardia XL® (nifedipine) tablet package insert. New York: Division of Pfizer Inc.
- United States Pharmacopial Convention, Inc. (2002). The United States Pharmacopia (USP), vol. 25, Rockville, MD: Pharmacopial Convention, Inc., 1227–30.
- Abou-Auda H, Najjar T, Al-Khamis K, Al-Hadiya B, Ghilzai N, Al-Fawzan N. (2000). Liquid chromatographic assay of nifedipine in human plasma and its application to pharmacokinetic studies. J Pharm Biomed Anal, 22:241–9.
- Felton L, Haase M, Shah N, Zhang G, Infeld M, Malick A, (1995). Physical and enteric properties of soft gelatin capsules coated with Eudragit® L30 D-55. Int J Pharm, 113:17–24.
- Matthews J. (1989). Process for coating gelatin capsules. US Patent No. 4,816,259.
- Banker G. (1966). Film coating theory and practice. J Pharm Sci, 55:81–9.
- FMC Corporation. (1986). Aquacoat® application book. Philadelphia, PA.
- Sorasuchart W, Wardrop J, Ayres J. (1999). Drug release from spray layered and coated drug-containing beads: Effects of pH and comparison of different dissolution methods. Drug Dev Ind Pharm, 25(10):1093–8.
- Ahmed I. (2002). Chapter III: Development of a colonic delivery system, Ph.D. thesis, Oregon State University, Corvallis, OR.
- Rolin C. (1993). Pectin. In: Whistler R, BeMiller J, eds. Industrial gums, polysaccharides and their derivatives San Diego, CA: Academic Press, Inc.
- Thom D, Grant G, Morris E, Rees D. (1982). Characterization of cationic binding and gelation of poly-uronates by circular dichroism. Carbohydr Res, 100:29–42.
- Coca A, Sobrino J, Soler J, Modol J, Palos M, Minguez A, (1997). Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended release Diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension. J Cardiovasc Pharmacol, 29:316–22.
- Weber M, Tonkon M, Klein R. (1987). Effects of antihypertensive therapy on the circadian blood pressure pattern. Am J Med, 82(Suppl. 1A):50–2.